Search Results - "Lemiale, Laurence"

Pathology and Pathophysiology of Inhalational Anthrax in a Guinea Pig Model by Savransky, Vladimir, Sanford, Daniel C, Syar, Emily, Austin, Jamie L, Tordoff, Kevin P, Anderson, Michael S, Stark, Gregory V, Barnewall, Roy E, Briscoe, Crystal M, Lemiale-Biérinx, Laurence, Park, Sukjoon, Ionin, Boris, Skiadopoulos, Mario H

“…OA  Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Development of Next-Generation COVID-19 Vaccines: Biomedical Advanced Research and Development Authority (BARDA­)–Supported Phase 2b Study Designs by Wolfe, Daniel N, Arangies, Elizabeth, David, Gloria L, Armstrong, Brian, Scocca, Theresa Z, Fedler, Janel, Natarajan, Ramya, Zhou, James, Jayashankar, Lakshmi, Donis, Ruben, Nesin, Mirjana, Meissner, H Cody, Lemiale, Laurence, Kovacs, Gerald R, Rele, Shyam, Mason, Robin, Cao, Huyen

“…Abstract In response to the coronavirus disease 2019 (COVID-19) pandemic, vaccines were quickly and successfully developed and deployed, saving millions of…”
Get full text

Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults by Hopkins, Robert J, Kalsi, Gurdyal, Montalvo-Lugo, Victor M, Sharma, Mona, Wu, Yukun, Muse, Derek D, Sheldon, Eric A, Hampel, Frank C, Lemiale, Laurence

“…Highlights • AV7909 is a combination of BioThrax® (Anthrax Vaccine Absorbed) and CPG 7909 adjuvant. • AV7909 vaccine is being developed for anthrax…”
Get full text

Development of a guinea pig inhalational anthrax model for evaluation of post-exposure prophylaxis efficacy of anthrax vaccines by Perry, Mark R., Ionin, Boris, Barnewall, Roy E., Vassar, Michelle L., Reece, Joshua J., Park, Sukjoon, Lemiale, Laurence, Skiadopoulos, Mario H., Shearer, Jeffry D., Savransky, Vladimir

“…A next-generation anthrax vaccine candidate, AV7909, is being developed for post-exposure prophylaxis (PEP) of inhalational anthrax in combination with the…”
Get full text

Development of Next-Generation COVID-19 Vaccines: BARDA Supported Phase 2b Study Designs by Wolfe, Daniel N, Arangies, Elizabeth, David, Gloria L, Armstrong, Brian, Scocca, Theresa Z, Fedler, Janel, Natarajan, Ramya, Zhou, James, Jayashankar, Lakshmi, Donis, Ruben, Nesin, Mirjana, Meissner, H Cody, Lemiale, Laurence, Kovacs, Gerald R, Rele, Shyam, Mason, Robin, Cao, Huyen

“…In response to the COVID-19 pandemic, vaccines were quickly and successfully developed and deployed, saving millions of lives globally. While first generation…”
Get full text